adplus-dvertising
Connect with us

Sports

Health Canada received more Johnson & Johnson data on same day as U.S. approval – CBC.ca

Published

 on


Health Canada on Saturday received additional data required to inform its decision on Johnson & Johnson’s COVID-19 vaccine — the same day the shot was approved in the United States.

“We were waiting on some manufacturing data, and that came in yesterday. So we’re starting to look at that,” Dr. Supriya Sharma, Health Canada’s chief medical adviser, said Sunday on Rosemary Barton Live.

“It’s really difficult to predict exactly when we might make a final decision because it really depends on that data. But we’re looking at … the next couple of weeks.”

The data received on Saturday is what health regulators need to ensure that “every dose of the vaccine that comes off the production lines meets quality standards,” Sharma wrote in an email to CBC News.

The approval timeline depends on that information, but it also depends on whether regulators need to discuss any questions that arise with the manufacturer. Work that happens in the final stages of review — including finalizing a risk-management plan for monitoring the vaccine after authorization — must also be completed.

The two-week approval target takes those steps into consideration but doesn’t account for unexpected issues that could crop up, Sharma said.

The government authorized the use of a third vaccine, the Oxford-AstraZeneca shot, on Friday.

WATCH | Johnson & Johnson vaccine approval could come in the next couple of weeks:

Health Canada’s chief medical adviser, Dr. Supriya Sharma, said the agency is waiting on manufacturer data to make a determination on Johnson & Johnson’s single-dose COVID-19 vaccine, but contingent on that data, approval could come in the next few weeks. 9:23

Single-dose shot makes for easier rollout

In a global trial, the Johnson & Johnson vaccine, which was cleared by the U.S. Food and Drug Administration (FDA) on Saturday, was found to be 66 per cent effective at staving off moderate to severe illness and was 85 per cent effective at preventing the most serious outcomes. 

Canada has ordered 10 million doses of the vaccine, with options for up to 28 million more. 

The best vaccine for an individual is [the] one that you can get.– Health Canada chief medical adviser Dr. Supriya Sharma

“In terms of the committee meeting that the FDA had, we had observers there as well, so all of that helps make for a more efficient review,” Sharma told CBC chief political correspondent Rosemary Barton.

While the vaccine was approved as a one-shot regimen, the company is also testing the efficacy of administering two doses of its product.

“If a vaccine is only only dose, then that makes it easier for administration. You don’t have to do the followup to record people and track them down to get the second dose,” Sharma told Barton. “So all of that helps, but what really helps the most is getting as many vaccines authorized and get that supply in as quickly as possible.”

Not a question of ‘good’ and ‘bad’ vaccines

Now that more vaccines are earning approvals, Sharma said a “narrative” has emerged where people assume one shot confers better protection than another.

Efficacy, she said, simply means determining whether “something does what it’s supposed to do.” As far as COVID-19 vaccines are concerned, that means comparing one group of people who receive the shot against another group of people who didn’t and contrasting the number of cases in both groups.

“When we look across all the vaccines, the major five that are under review and authorized, if you look at that subsection that matters most — severe disease, hospitalizations, dying of COVID-19 — all of these vaccines are equally protective,” Sharma explained.

The chief medical adviser cautioned against pitting one shot against another, something she said can only happen in a “head-to-head” trial, which would see two vaccines being tested together in the same trial.

“The best vaccine for an individual is [the] one that you can get. That’s pretty simple,” she said.

“For people who are sitting back and waiting for another vaccine, I would say the longer, and the more people, who do that, the more we’re all going to be sitting at home if we’re lucky to have a home.”

You can watch full episodes of Rosemary Barton Live on CBC Gem, the CBC’s streaming service. 

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Sports

Edler to sign one-day contract to retire as a Vancouver Canuck

Published

 on

 

VANCOUVER – The Vancouver Canucks announced Tuesday that defenceman Alex Edler will sign a one-day contract in order to officially retire as a member of the NHL team.

The signing will be part of a celebration of Edler’s career held Oct. 11 when the Canucks host the Philadelphia Flyers.

The Canucks selected Edler, from Ostersund, Sweden, in the third round (91st overall) of the 2004 NHL draft.

He played in 925 career games for the Canucks between the 2006-07 and 2020-21 seasons, ranking fourth in franchise history and first among defencemen.

The 38-year-old leads all Vancouver defencemen with 99 goals, 310 assists and 177 power-play points with the team.

Edler also appeared in 82 career post-season contests with Vancouver and was an integral part of the Canucks’ run to the 2011 Stanley Cup final, putting up 11 points (2-9-11) across 25 games.

“I am humbled and honoured to officially end my career and retire as a member of the Vancouver Canucks,” Edler said in a release. “I consider myself lucky to have started my career with such an outstanding organization, in this amazing city, with the best fans in the NHL. Finishing my NHL career where it all began is something very special for myself and my family.”

Edler played two seasons for Los Angeles in 2021-22 and 2022-23. He did not play in the NHL last season.

This report by The Canadian Press was first published Sept. 17, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Sports

Sixth-ranked Canadian women to face World Cup champion Spain in October friendly

Published

 on

 

The sixth-ranked Canadian women will face World Cup champion Spain in an international friendly next month.

Third-ranked Spain will host Canada on Oct. 25 at Estadio Francisco de la Hera in Almendralejo.

The game will be the first for the Canadian women since the Paris Olympics, where they lost to Germany in a quarterfinal penalty shootout after coach Bev Priestman was sent home and later suspended for a year by FIFA over her part in Canada’s drone-spying scandal.

In announcing the Spain friendly, Canada Soccer said more information on the interim women’s coaching staff for the October window will come later. Assistant coach Andy Spence took charge of the team in Priestman’s absence at the Olympics.

Spain finished fourth in Paris, beaten 1-0 by Germany in the bronze-medal match.

Canada is winless in three previous meetings (0-2-1) with Spain, most recently losing 1-0 at the Arnold Clark Cup in England in February 2022.

The teams played to a scoreless draw in May 2019 in Logroñés, Spain in a warm-up for the 2019 World Cup. Spain won 1-0 in March 2019 at the Algarve Cup in São João da Venda, Portugal.

Spain is a powerhouse in the women’s game these days.

It won the FIFA U-20 World Cup in 2022 and was runner-up in 2018. And it ousted Canada 2-1 in the round of 16 of the current U-20 tournament earlier this month in Colombia before falling 1-0 to Japan after extra time in the quarterfinal.

Spain won the FIFA U-17 World Cup in 2018 and 2022 and has finished on the podium on three other occasions.

FC Barcelona’s Aitana Bonmati (2023) and Alexia Putellas (2021 and ’22) have combined to win the last three Women’s Ballon d’Or awards.

And Barcelona has won three of the last four UEFA Women’s Champions League titles.

“We continue to strive to diversify our opponent pool while maintaining a high level of competition.” Daniel Michelucci, Canada Soccer’s director of national team operations, said in a statement. “We anticipate a thrilling encounter, showcasing two of the world’s top-ranked teams.”

This report by The Canadian Press was first published Sept. 17, 2024

The Canadian Press. All rights reserved.

Source link

Continue Reading

Sports

Maple Leafs announce Oreo as new helmet sponsor for upcoming NHL season

Published

 on

 

TORONTO – The Toronto Maple Leafs have announced cookie brand Oreo as the team’s helmet sponsor for the upcoming NHL season.

The new helmet will debut Sunday when Toronto opens its 2024-25 pre-season against the Ottawa Senators at Scotiabank Arena.

The Oreo logo replaces Canadian restaurant chain Pizza Pizza, which was the Leafs’ helmet sponsor last season.

Previously, social media platform TikTok sponsored Toronto starting in the 2021-22 regular season when the league began allowing teams to sell advertising space on helmets.

The Oreo cookie consists of two chocolate biscuits around a white icing filling and is often dipped in milk.

Fittingly, the Leafs wear the Dairy Farmers of Ontario’s “Milk” logo on their jerseys.

This report by The Canadian Press was first published Sept. 17, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending